
Talxone-SB 1gm/0.5gm Injection
Marketer
Talson Pharmaceuticals
Salt Composition
Ceftriaxone (1gm) + Sulbactam (0.5gm)
Overview Talxone-SB 1gm/0.5gm Injection
Combiflox-DUO 1g/0.5g Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under medical guidance; strictly adhere to the prescribed schedule and complete the entire course, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Talxone-SB 1gm/0.5gm Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Talxone-SB 1gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Talxone-SB 1gm/0.5gm Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strongly discouraged.
Common Side effects of Talxone-SB 1gm/0.5gm Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Talxone-SB 1gm/0.5gm Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Talxone-SB 1gm/0.5gm Injection works:
The injectable formulation Talxone-SB (1g Ceftriaxone/0.5g Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial mechanism disrupts bacterial cell wall synthesis, hindering their viability. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Talxone-SB 1gm/0.5gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Talxone-SB (1gm/0.5gm) is typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Talxone-SB 1gm/0.5gm Injection to breastfeeding mothers requires careful consideration. Lactation should be discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Talxone-SB 1gm/0.5gm Injection may induce drowsiness, visual disturbances, or dizziness. Driving is contraindicated if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Talxone-SB 1gm/0.5gm Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Talxone-SB 1gm/0.5gm Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification of Talxone-SB 1gm/0.5gm Injection may be necessary; physician consultation is advised. Altering the Talxone-SB 1gm/0.5gm Injection dose is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Talxone-SB 1gm/0.5gm Injection :
Omit a Talxone-SB 1gm/0.5gm Injection dose? Seek medical advice immediately.
Facts to Know About Talxone-SB 1gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
